Multiple sclerosis: new therapeutic concepts or better use of old drugs?
Clanet
M
M
D000284:Administration, Oral; D001921:Brain / Q000187:drug effects / Q000473:pathology; D004185:Disability Evaluation; D006801:Humans; D007279:Injections, Subcutaneous; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000008:administration & dosage*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000628:therapy*; D009185:Myelin Proteins / Q000008:administration & dosage*; D011994:Recombinant Proteins / Q000008:administration & dosage
D009185:Myelin Proteins; D011994:Recombinant Proteins; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a